On September 3, 2026, DL HOLDINGS GP (01709.HK) announced that its Bitcoin mining business had produced an aggregate of 506.228 Bitcoins since commencing on November 12, 2025, with 405.00 Bitcoins sold at an average price of approximately USD 74,021 each for approximately USD 29.98 million in realized value, and 101.228 Bitcoins still held as of September 2, 2026. The average electricity cost per Bitcoin has declined from a cumulative approximately USD 54,500 to approximately USD 50,000 in August 2026, and the group expects to produce approximately 240 to 264 Bitcoins during the remaining period ending December 31, 2026; the figures have not been audited or reviewed by the company's auditors.
On September 3, 2026, SBP GROUP (01177.HK) announced that TQB6426, a national Class 1 innovative drug and a GPC3-targeting antibody-drug conjugate independently developed by its subsidiary Chia Tai Tianqing Pharmaceutical Group Co., Ltd., had received IND approval from the US FDA for advanced malignant tumors. GPC3 is highly expressed in hepatocellular carcinoma and no GPC3-targeting ADC has been approved worldwide; the group will accelerate the Phase I clinical trial to evaluate the drug's safety, tolerability, pharmacokinetic profile and preliminary efficacy.
On September 3, 2026, TWINTEK (06182.HK) announced that Mars Nest Limited, its controlling shareholder, had sold 510,000,000 shares of the company, representing approximately 63.75% of its total issued share capital; immediately upon completion, Mars Nest no longer held any shares and ceased to be the controlling shareholder. The company cautioned shareholders and potential investors to act with prudence when dealing in its shares.
On September 3, 2026, ASYMCHEM (06821.HK) issued an overseas regulatory announcement stating that 1,027,575 A shares under the first release tranche of the initial grant of its 2025 A-share restricted share incentive plan, representing 0.3087% of its A-share capital and involving 540 grantees, will be released from trading restrictions and listed for trading on September 7, 2026. The first sales restriction period ended on September 4, 2026, and the company's 2025 revenue of RMB 6.670 billion, up 16.78% at constant exchange rates, satisfied the performance assessment requirements.
On September 3, 2026, EDICO HOLDINGS (08450.HK) issued a supplementary announcement stating that financial printing remains its principal business with no intention to downscale it in the next twelve months, with interim revenue up approximately 47.1% to approximately HKD 12.6 million, and that the company holds a 51% interest in and majority control over HKTCG, the vehicle of its trading card business. In response to a Sing Tao news article, the company clarified that cards worth approximately HKD 80 million displayed in its retail stores include collectors' own property for exhibition purposes only, and that the reported outlay of approximately HKD 60 million by Mr. Chung reflects an estimate of potential resources for the card business over the next three to five years rather than an actual investment.
NewTimeSpace News: September 03, 2026, SMARTONE TELE(00315.HK) released its Annual Report for the period ended June 30, 2026, Total Revenue stood at HKD 6.6 billion, increased by 5.6% YoY.
On September 3, 2026, MEDIA CHINESE (00685.HK) announced that its indirect wholly-owned subsidiary Ming Pao Holdings (Canada) Limited had agreed to dispose of a property in Richmond, Canada, formerly used as the group's media office and printing plant, to Da Xing Investment Ltd. for CAD 6.85 million (approximately USD 4.92 million), expecting to record an unaudited gain of approximately CAD 5.26 million, with net proceeds of approximately CAD 6.55 million planned for general working capital. The disposal constitutes a discloseable transaction, with completion expected on December 1, 2026.
On September 3, 2026, CMS (00867.HK) announced that its subsidiary Dermavon Holdings Limited had obtained NMPA approval and a drug registration certificate for ruxolitinib phosphate cream (Bailutuo) in mild-to-moderate atopic dermatitis, the product's second approved indication in China following vitiligo in January 2026. Phase III data showed 8-week IGA response of 63.0% versus 9.2% for placebo and EASI 75 response of 78.0% versus 15.4% (P<0.001); the product was in-licensed through a collaboration and license agreement with Incyte signed in December 2022.
On September 3, 2026, NIMBLE HOLDINGS (00186.HK) announced the signing of a construction service framework agreement under which the group may engage a connected contractor for engineering and related services until March 31, 2029, subject to approval by independent shareholders. Proposed annual caps for the years ending March 31, 2027, 2028 and 2029 are RMB 68 million, RMB 134 million and RMB 177 million, respectively, with transactions under the existing construction contract aggregated; Mr. Tan and his associates holding approximately 73.85% of the shares will abstain from voting, and the circular is expected on or around September 15, 2026.
On 3 September 2026, CMS (00867.HK) announced that its subsidiary Deme Medical's ruxolitinib cream Baicor has been approved by the NMPA for mild-to-moderate atopic dermatitis (registration certificate received on 3 September), marking its second indication after vitiligo.
On September 3, Hong Kong stocks opened higher but closed lower, with the Hang Seng Index down 0.39% to 25,213.31 points and the Hang Seng TECH Index down 1.08%, on turnover of HKD 199.38 billion. Innovative drug plays surged, with HUTCHMED (00013) rising 14.32% on a licensing collaboration with GSK worth more than USD 1.4 billion in total; SBP GROUP rose 6.27%. Non-ferrous metals including gold rallied against the trend while internet stocks closed lower across the board. Southbound capital recorded net purchases of HKD 3.395 billion. Baidu completed its dual primary listing and could be included in Stock Connect as early as September 7; Moonshot AI reportedly filed confidentially; SHEIN-W will be included in the Hang Seng Composite Index on September 15, with its shares hitting a fresh low. MINIMAX-W rose 3.6%, up more than 20% this week.
NewTimeSpace (newtimespace.com) reported that on September 3, 2026,the Hang Seng Index fell 0.39%, the Hang Seng TECH Index fell 1.08%, and the Hang Seng China Enterprises Index fell 0.77%. The Hang Seng Index's full-day turnover was HK$199.4 billion, Southbound funds recorded a net inflow of HK$3.395 billion.
On 3 September 2026, SINOPEC SSC (01033.HK) announced that Mr. Wu Bozhi has resigned as chairman, legal representative, executive director and chairman of the Strategy Committee due to work adjustments, effective the same date; the resignation has not caused the Board to fall below the quorum, and general manager Mr. Zhang Jiankuo will perform the duties of legal representative until a new chairman is elected.
On 3 September 2026, ALLAN INT'L (00684.HK) announced that its public float of 24.04% remains below the 25% level required under the Listing Rules, with the restoration deadline expected to be extended by a further six months from the announcement date to March 2027; the Company is considering alternatives other than disposals by connected persons and a share scheme, and will continue to publish monthly updates.
On 3 September 2026, CIPRUN TECH (01020.HK) announced the appointment of Mr. Li Fushan as a non-executive director with effect from the same date for a term of two years; Mr. Li has over 20 years of experience in intellectual property management, previously serving at Tencent Holdings and Skyworth Group, and is currently the legal representative of Guangdong Zhicheng Intellectual Property Research Institute.
On September 3, 2026, gold miner and Taiwan/Japan ETFs led the gains in the HK shares ETFs market. E Fund (HK) Solactive Global Gold Miner Select Index ETF (2824.HK) rose 3.98%, and iShares Core MSCI Taiwan Index ETF (3074.HK) advanced 3.24%; ICBC UBS KraneShares KWEB CSI China Internet ETF (3102.HK) fell 1.59%, while Hang Seng TECH and high-dividend yield ETFs pulled back moderately. NewTimeSpace monitoring shows an evident rotation pattern in which gold and regional markets strengthened while Hang Seng TECH came under pressure.
